Outcomes and Risk Factors for Liver Transplantation Using Significant Fibrotic Grafts

Outcomes and Risk Factors for Liver Transplantation Using Significant Fibrotic Grafts: a Retrospective Cohort Analysis of the US National Database

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07101718

Enrollment

25419

Registered

2025-08-03

Start date

2024-07-01

Completion date

2024-12-31

Last updated

2025-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Transplant

Brief summary

This is a multi-center study to investigate the impact of fibrotic liver greafts in liver transplant recipient.

Interventions

OTHERNo intervention

No intervention

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

patients receiving liver transplantation during the period from March 2015 to March 2024

Exclusion criteria

1. recipients under 18 years old 2. re-transplantation cases 3. multiorgan transplant cases, reduced-size or split LT cases 4. lacking follow-up records or graft biopsy records

Design outcomes

Primary

Measure	Time frame	Description
Overall survival rates	January 2015 to December 2024	The overall survival of liver transplant recipients.

Secondary

Measure	Time frame	Description
Graft survival rates	January 2015 to December 2024	The graft survival of liver transplant recipients.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026